XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Assets    
Cash and due from banks $ 280,915 $ 257,845
Interest bearing deposits with banks 1,352,918 1,071,360
Investment securities:    
Equity securities 32,973 29,378
Available for sale debt securities 1,116,221 1,339,473
Held to maturity debt securities (net of allowance for credit losses of $1,070 at March 31, 2021 and $1,428 at December 31, 2020) 2,389,956 2,171,583
Total investment securities 3,539,150 3,540,434
Loans held for sale, at fair value 232,068 301,427
Loans 32,686,416 32,217,112
Less: Allowance for loan losses (342,880) (340,243)
Net loans 32,343,536 31,876,869
Premises and equipment, net 323,841 319,797
Lease right of use assets 242,190 252,053
Bank owned life insurance 535,620 535,209
Accrued interest receivable 107,790 106,230
Goodwill 1,382,442 1,382,442
Other intangible assets, net 67,972 70,449
Other assets 769,569 971,961
Total Assets 41,178,011 40,686,076
Deposits:    
Non-interest bearing 10,053,026 9,205,266
Interest bearing:    
Savings, NOW and money market 17,081,105 16,015,658
Time 5,451,078 6,714,678
Total deposits 32,585,209 31,935,602
Short-term borrowings 1,084,666 1,147,958
Long-term borrowings 2,242,931 2,295,665
Junior subordinated debentures issued to capital trusts 56,152 56,065
Lease liabilities 266,407 276,675
Accrued expenses and other liabilities 282,976 381,991
Total Liabilities 36,518,341 36,093,956
Shareholders’ Equity    
Common stock (no par value, authorized 650,000,000 shares; issued 405,801,304 shares at March 31, 2021 and 403,881,488 shares at December 31, 2020) 142,435 141,746
Surplus 3,651,948 3,637,468
Retained earnings 672,651 611,158
Accumulated other comprehensive loss (17,005) (7,718)
Treasury stock, at cost (3,766 common shares at March 31, 2021 and 22,490 common shares at December 31, 2020) (50) (225)
Total Shareholders’ Equity 4,659,670 4,592,120
Total Liabilities and Shareholders’ Equity 41,178,011 40,686,076
Series A    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares 111,590 111,590
Series B    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares $ 98,101 $ 98,101